Your browser doesn't support javascript.
loading
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Sharma, Hitt; Anil, K; Parekh, Sameer; Pujari, Pramod; Shewale, Sunil; Desai, Shivani; Madhusudhan, R L; Patel, Jaya; Eswaraiah, Anand; Rao, Harish; Gairola, Sunil; Shaligram, Umesh.
Affiliation
  • Sharma H; Serum Institute of India Pvt. Ltd., Pune, India.
  • Anil K; Syngene International Limited, Bangalore, India.
  • Parekh S; Serum Institute of India Pvt. Ltd., Pune, India.
  • Pujari P; Serum Institute of India Pvt. Ltd., Pune, India.
  • Shewale S; Serum Institute of India Pvt. Ltd., Pune, India.
  • Desai S; Serum Institute of India Pvt. Ltd., Pune, India.
  • Madhusudhan RL; Syngene International Limited, Bangalore, India.
  • Patel J; Syngene International Limited, Bangalore, India.
  • Eswaraiah A; Syngene International Limited, Bangalore, India.
  • Rao H; Serum Institute of India Pvt. Ltd., Pune, India.
  • Gairola S; Serum Institute of India Pvt. Ltd., Pune, India.
  • Shaligram U; Serum Institute of India Pvt. Ltd., Pune, India.
Vaccine X ; 14: 100313, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37234594
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Year: 2023 Type: Article